Chemical Compound

C16 Ceramide

CAS Registry Number 24696-26-2
Back to search Request a Quote
C16 Ceramide chemical structure
Primary Record

C16 Ceramide

In stock
3,151 g
Purity
99.0 %
CAS
24696-26-2

Compound Identifiers & Properties

CAS
24696-26-2
PubChem CID
5283564
SMILES
CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@@H](/C=C/CCCCCCCCCCCCC)O
Canonical SMILES
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCC

Names & Synonyms

  • C16 Ceramide
  • C16-ceramide
  • N-Palmitoylsphingosine
  • ceramide
  • N-acylsphingosine
  • Palmitoyl ceramide
  • N-palmitoyl-sphingosine
  • Ceramide (Egg)
  • N-hexadecanoylsphingosine
  • C16 Cer
  • Ceramide d34:1
  • N-(palmitoyl)-ceramide
  • 24696-26-2
  • C16:0-Ceramide
  • N-(palmitoyl)ceramide
  • N-palmitoyl-D-erythro-sphingosine
  • Cer[NS]
  • Ceramide (Egg, Chicken)
  • N-(hexadecanoyl)-ceramide
  • Cer(d18:1/16:0)
  • N-(hexadecanoyl)ceramide
  • AC1NR2KG
  • N-(hexadecanoyl)-sphing-4-enine
  • RefChem:573083
  • N-palmitoylsphing-4-enine
  • C16-d-Erythro-sphingosine
  • CHEMBL35292
  • Epitope ID:233996
  • C16-0(Palmitoyl)ceramide
  • FD38GFZ87C
  • N-Hexadecanoyl-D-sphingosine
  • N-hexadecanoylsphing-4-enine
  • sphing-4-enine-16-ceramide
  • (4E)-N-Palmitoylsphingenine
  • BSPBio_001281
  • CHEBI:72959
  • N-PALMITOYL-D-SPHINGOSINE
  • Cer 34:1
  • YDNKGFDKKRUKPY-TURZORIXSA-N
  • BML3-D03
  • DTXSID301317974
  • C16 Ceramide (d18:1/16:0)
  • N-(hexadecanoyl)sphing-4-enine
  • Ceramide (d18:1/16:0)
  • SCHEMBL10298591
  • C34H67NO3
  • Ceramide (18:1/16:0)
  • N-hexadecanoyl-D-erythro-sphingosine
  • D-erythro-Sphingosine, N-Palmitoyl-
  • DTXCID501747767
  • GLXC-15996
  • GLXC-27248
  • HMS1361A03
  • HMS1791A03
  • HMS1989A03
  • HMS3402A03
  • CUA24306
  • ZINC8860497
  • BDBM50289523
  • LMSP02010004
  • MFCD00056205
  • MFCD00871748
  • MSK005012
  • AKOS040755906
  • CID5283564
  • IDI1_033751
  • NCGC00161362-01
  • NCGC00161362-02
  • NCGC00161362-03
  • BP-28815
  • N-(1,3-dihydroxyoctadec-4-en-2-yl)hexadecanamide
  • HY-100354
  • J525.581C
  • N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  • CS-0018668
  • FT-0623353
  • (2S,3R,4E)-2-acylamino-1,3-octadec-4-enediol
  • (2S,3R,4E)-2-acylaminooctadec-4-ene-1,3-diol
  • J2.856.006K
  • N-Palmitoyl-D-sphingosine, >=98.0% (TLC)
  • G90989
  • N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)palmitamide
  • N-((E,2s,3r)-1,3-Dihydroxyoctadec-4-En-2-Yl)palmitamide
  • C16 Ceramide (N-Palmitoylsphingosine, D-erythro)
  • N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  • A1202123
  • (2S,3R)-2-(Hexadecanoylamino)-4-octadecene-1,3-diol
  • (2S,3R,4E)-2-(Palmitoylamino)-4-octadecene-1,3-diol
  • Hexadecanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-
  • B1370-059982
  • 4201-58-5
  • N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  • N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecene-2-yl]hexadecanamide
  • 477243-06-4
  • C16 Ceramide (d18:1/16:0), N-palmitoyl-D-erythro-sphingosine, powder
  • N-[(1S,2R)-1-(Hydroxymethyl)-2-hydroxy-3-heptadecene-1-yl]hexadecanamide
  • N-[(1S,2R)-1-(Hydroxymethyl)-2-hydroxy-3-heptadecenyl]hexadecanamide
  • N-[(1S,2R,3E)-1-(Hydroxymethyl)-2-hydroxy-3-heptadecenyl]hexadecanamide
  • N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide
  • N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]hexadecanamide
  • N-[(E,1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadec-3-enyl]hexadecanamide
  • N-Palmitoyl-D-sphingosine semisynthetic from bovine brain D-sphingosine
  • Hexadecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
  • Hexadecanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
  • Hexadecanoic acid ((E)-(1S,2R)-2-hydroxy-1-hydroxymethyl-heptadec-3-enyl)-amide
  • N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]hexadecanamide
  • N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]hexadecanamide
  • N-Palmitoyl-D-erythro-sphingosine;N-Hexadecanoyl-D-erythro-sphingosine;N-Palmitoyl ceramide
  • 16C
  • 640-541-5
  • CER
  • Hexadecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-; Hexadecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]- (9CI); Hexadecanamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-; N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]hexadecanamide; (2S,3R,4E)-2-N-Palmitoyloctadecasphinga-4-ene; C16-Ceramide; C16-Ceramide; C16:0-Ceramide; Ceramide 16; D-erythro-C16-Ceramide; D-erythro-N-Hexadecanoylsphingenine; D-erythro-N-Palmitoylsphingosine; D-erythro-?4-Ceramide; N-Hexadecanoyl-D-erythro-ceramide; N-Hexadecanoylsphingosine; N-Palmitoyl 4-sphingenine; N-Palmitoyl ceramide; N-Palmitoyl-D-erythro-sphingosine; N-Palmitoyl-D-sphingosine; N-Palmitoylsphingosine